CIK 0001484612 · Accelerated filer<br>Smaller reporting company
Outset Medical, Inc.
Sign in to watch- Ticker
- OM
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 200514392
- Phone
- 669-231-8200
- Business address
- 3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
- Former names
- Home Dialysis Plus, Ltd.
- Open-market buys, last 90 days
- $870,260
- in 1 filing
- Open-market sales, last 90 days
- $46,587
- in 3 filings
Net +$823,674. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-18 | Nash Marc SVP Operations and R&D | Sale | −4,204 | $0.90 | $4K | 200,764 |
| 2025-02-18 | Brottem John L. General Counsel | Sale | −6,145 | $0.90 | $6K | 175,043 |
| 2025-02-18 | Ahmed Nabeel Chief Financial Officer | Sale | −8,659 | $0.90 | $8K | 250,210 |
| 2025-01-21 | Trigg Leslie Chair and CEO | Sale | −4,403 | $0.80 | $4K | 956,413 |
| 2025-01-21 | Trigg Leslie Chair and CEO | Sale | −42,384 | $0.80 | $34K | 914,029 |
| 2025-01-21 | Trigg Leslie Chair and CEO | Sale | −18,449 | $0.80 | $15K | 895,580 |
| 2025-01-21 | Nash Marc SVP Operations and R&D | Sale | −356 | $0.80 | $285 | 227,833 |
| 2025-01-21 | Nash Marc SVP Operations and R&D | Sale | −21,590 | $0.80 | $17K | 206,243 |
| 2025-01-21 | Nash Marc SVP Operations and R&D | Sale | −971 | $0.80 | $777 | 205,272 |
| 2025-01-21 | Nash Marc SVP Operations and R&D | Sale | −304 | $0.80 | $243 | 204,968 |
| 2025-01-21 | Brottem John L. General Counsel | Sale | −777 | $0.80 | $622 | 213,341 |
| 2025-01-21 | Brottem John L. General Counsel | Sale | −29,474 | $0.80 | $24K | 183,867 |
| 2025-01-21 | Brottem John L. General Counsel | Sale | −2,679 | $0.80 | $2K | 181,188 |
| 2025-01-21 | Ahmed Nabeel Chief Financial Officer | Sale | −907 | $0.80 | $726 | 292,250 |
| 2025-01-21 | Ahmed Nabeel Chief Financial Officer | Sale | −29,474 | $0.80 | $24K | 262,776 |
| 2025-01-21 | Ahmed Nabeel Chief Financial Officer | Sale | −3,907 | $0.80 | $3K | 258,869 |
| 2025-01-17 | Trigg Leslie Chair and CEO | Grant or award | +99,419 | 960,816 | ||
| 2025-01-17 | Nash Marc SVP Operations and R&D | Grant or award | +4,494 | 226,785 | ||
| 2025-01-17 | Nash Marc SVP Operations and R&D | Grant or award | +1,404 | 228,189 | ||
| 2025-01-17 | Brottem John L. General Counsel | Grant or award | +9,090 | 214,118 |
Page 5 of 8 · 141 trades